Bimatoprost .03% sterile ophthalmic solution

DRUG2 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Federal University of São Paulo

Conditions

GlaucomaOcular HypertensionQuality of Life (QOL)

Phase 4

Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US

CompletedNCT00847483

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Glaucoma, Ocular Hypertension

Start: 2002-01-31End: 2002-08-31Updated: 2021-02-02

Triplenex (triple Fixed Combination) Use Evaluation in Patients with Glaucoma

Active, not recruitingNCT06761313

Federal University of São PauloGlaucoma, Quality of Life (QOL)

Start: 2021-03-01End: 2025-02-26Target: 40Updated: 2025-01-07